核受体相互作用蛋白1 (nuclear receptor interacting protein 1, NRIP1),也称为受体相互作用蛋白140 (Receptor Interacting Protein of 140 kDa, RIP140),是一种转录共调节因子,参与调控多种生理过程,其功能异常可能导致疾病发生。与...核受体相互作用蛋白1 (nuclear receptor interacting protein 1, NRIP1),也称为受体相互作用蛋白140 (Receptor Interacting Protein of 140 kDa, RIP140),是一种转录共调节因子,参与调控多种生理过程,其功能异常可能导致疾病发生。与其他主要发挥共激活或共抑制作用的共调节因子不同,NRIP1在基因调控中具有独特的双重功能——既能作为共激活因子,也能作为共抑制因子发挥作用。近年来,随着研究的深入,科学家们逐渐揭示了NRIP1在肿瘤发生发展过程中的重要调控作用。本文重点综述NRIP1在乳腺癌、口腔鳞状细胞癌、肠道肿瘤、血液系统肿瘤等多种恶性肿瘤中的分子调控机制。展开更多
目的探讨心脏组织特异性过表达受体相互作用蛋白140(receptor interacting protein 140,RIP140)对心脏功能及炎症通路的影响。方法大鼠心脏组织多点注射携带RIP140基因的腺病毒载体,使心肌组织过表达RIP140;免疫荧光验证RIP140蛋白在心...目的探讨心脏组织特异性过表达受体相互作用蛋白140(receptor interacting protein 140,RIP140)对心脏功能及炎症通路的影响。方法大鼠心脏组织多点注射携带RIP140基因的腺病毒载体,使心肌组织过表达RIP140;免疫荧光验证RIP140蛋白在心脏组织中的过表达情况;超声心动图与血流动力学参数评估心脏功能;ELISA分析TNF-α、IL-2、IL-1β等炎症因子水平;Western blot分析p65、IκB-α的蛋白水平。结果腺病毒载体介导的外源基因RIP140可成功过表达于心脏组织,诱导心室扩张、左室射血分数下降、心功能受损,促进心肌组织TNF-α、IL-2、IL-1β炎症因子释放,p65蛋白入核、胞质IκB-α蛋白降解。结论腺病毒介导RIP140基因在心脏组织中的特异性过表达损伤心脏功能,激活NF-κB/p65炎症通路,促进炎症因子释放。展开更多
受体相互作用蛋白140(receptor-interacting protein 140,RIP140)作为一种转录辅抑制因子,参与机体代谢调节。RIP140与核受体结合后能够负向调节脂肪、肌肉、心肌以及肝脏等多种组织中靶基因的转录。对其进行靶向沉默可上调多种组织中...受体相互作用蛋白140(receptor-interacting protein 140,RIP140)作为一种转录辅抑制因子,参与机体代谢调节。RIP140与核受体结合后能够负向调节脂肪、肌肉、心肌以及肝脏等多种组织中靶基因的转录。对其进行靶向沉默可上调多种组织中相关基因的表达,影响糖酵解、甘油三酯代谢、三羧酸循环、脂肪酸β氧化、炎症因子表达以及机体时钟变化等多种代谢过程,因此RIP140有望成为治疗代谢综合征的候选靶点。展开更多
Estrogen receptors and E2F transcription factors are the key players of two nuclear signaling pathways which exert a major role in oncogenesis, particularly in the mammary gland. Different levels of dialogue between t...Estrogen receptors and E2F transcription factors are the key players of two nuclear signaling pathways which exert a major role in oncogenesis, particularly in the mammary gland. Different levels of dialogue between these two pathways have been deciphered and deregulation of the E2F pathway has been shown to impact the response of breast cancer cells to endocrine therapies. The present review focuses on the transcriptional coregulator RIP140/NRIP1 which is involved in several regulatory feed-back loops and inhibitory cross-talks between different nuclear signaling pathways. RIP140 regulates the transactivation potential of estrogen receptors and E2Fs and is also a direct transcriptional target of these transcription factors. Published data highlight the complex regulation of RIP140 expression at the transcriptional level and its potential role in transcription cross-talks. Indeed, a subtle regulation of RIP140 expression levels has important consequences on other transcription networks targeted by this coregulator. Another level of regulation implies titration mechanisms by which activation of a pathway leads to sequestration of the RIP140 protein and thus impinges other gene regulatory circuitries. Altogether, RIP140 occupies a place of choice in the dialogue between nuclear receptors and E2Fs, which could be highly relevant in various human pathologies such as cancer or metabolic diseases.展开更多
文摘核受体相互作用蛋白1 (nuclear receptor interacting protein 1, NRIP1),也称为受体相互作用蛋白140 (Receptor Interacting Protein of 140 kDa, RIP140),是一种转录共调节因子,参与调控多种生理过程,其功能异常可能导致疾病发生。与其他主要发挥共激活或共抑制作用的共调节因子不同,NRIP1在基因调控中具有独特的双重功能——既能作为共激活因子,也能作为共抑制因子发挥作用。近年来,随着研究的深入,科学家们逐渐揭示了NRIP1在肿瘤发生发展过程中的重要调控作用。本文重点综述NRIP1在乳腺癌、口腔鳞状细胞癌、肠道肿瘤、血液系统肿瘤等多种恶性肿瘤中的分子调控机制。
文摘目的探讨心脏组织特异性过表达受体相互作用蛋白140(receptor interacting protein 140,RIP140)对心脏功能及炎症通路的影响。方法大鼠心脏组织多点注射携带RIP140基因的腺病毒载体,使心肌组织过表达RIP140;免疫荧光验证RIP140蛋白在心脏组织中的过表达情况;超声心动图与血流动力学参数评估心脏功能;ELISA分析TNF-α、IL-2、IL-1β等炎症因子水平;Western blot分析p65、IκB-α的蛋白水平。结果腺病毒载体介导的外源基因RIP140可成功过表达于心脏组织,诱导心室扩张、左室射血分数下降、心功能受损,促进心肌组织TNF-α、IL-2、IL-1β炎症因子释放,p65蛋白入核、胞质IκB-α蛋白降解。结论腺病毒介导RIP140基因在心脏组织中的特异性过表达损伤心脏功能,激活NF-κB/p65炎症通路,促进炎症因子释放。
文摘受体相互作用蛋白140(receptor-interacting protein 140,RIP140)作为一种转录辅抑制因子,参与机体代谢调节。RIP140与核受体结合后能够负向调节脂肪、肌肉、心肌以及肝脏等多种组织中靶基因的转录。对其进行靶向沉默可上调多种组织中相关基因的表达,影响糖酵解、甘油三酯代谢、三羧酸循环、脂肪酸β氧化、炎症因子表达以及机体时钟变化等多种代谢过程,因此RIP140有望成为治疗代谢综合征的候选靶点。
文摘Estrogen receptors and E2F transcription factors are the key players of two nuclear signaling pathways which exert a major role in oncogenesis, particularly in the mammary gland. Different levels of dialogue between these two pathways have been deciphered and deregulation of the E2F pathway has been shown to impact the response of breast cancer cells to endocrine therapies. The present review focuses on the transcriptional coregulator RIP140/NRIP1 which is involved in several regulatory feed-back loops and inhibitory cross-talks between different nuclear signaling pathways. RIP140 regulates the transactivation potential of estrogen receptors and E2Fs and is also a direct transcriptional target of these transcription factors. Published data highlight the complex regulation of RIP140 expression at the transcriptional level and its potential role in transcription cross-talks. Indeed, a subtle regulation of RIP140 expression levels has important consequences on other transcription networks targeted by this coregulator. Another level of regulation implies titration mechanisms by which activation of a pathway leads to sequestration of the RIP140 protein and thus impinges other gene regulatory circuitries. Altogether, RIP140 occupies a place of choice in the dialogue between nuclear receptors and E2Fs, which could be highly relevant in various human pathologies such as cancer or metabolic diseases.
